Skip to main content

GSA CAPITAL PARTNERS LLP

Position in SCYX — Scynexis Inc

CIK 1362033 LONDON, X0

Position in SCYX

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$80,276
-$21,465 QoQ
Shares Held
10,943
-45.6% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SCYX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $11,914,926 across 21 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in SCYX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $80,276 87,542
2025-12-31 $101,741 160,983
2025-09-30 $80,405 104,423
2025-06-30 $36,117 53,507
2024-06-30 $84,354 42,177
2024-03-31 $34,534 23,493
2023-12-31 $82,701 37,086
2023-09-30 $39,724 17,423
2021-09-30 $476,120 89,834
2021-06-30 $821,773 111,654
2021-03-31 $264,322 33,290
2020-12-31 $109,892 14,365
2020-09-30 $93,628 21,231
2020-06-30 $59,350 79,029